Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
1 clinical trials · Condition
◉ Watch Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
| Record | Firm | Date |
|---|---|---|
| Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components (NCT05266404) | AstraZeneca | 2022-03-21 |
Track Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus) automatically
Every clearance here is in the API, with alerts when new ones post.